Implications of CXCR3 Expression on Myeloid Cells for Immunotherapy of Cancer and Myeloid-mediated Disease
Technology
E-009-2023
Patent ID
E-009-2023-0-US-01
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/423,029
IC
NCI
Date Filed
Date Issued
Patent PDF